Capturing the Kingdom: Saudi Arabia’s Differentiated Strategy to Dominate the MENA Pharmaceutical Market

Published: December 08, 2025 • Categories: Global Policy, Manufacutring, Global Biopharma

Your JPMHC Cheat Sheet: Insider Tactics to Own the Meeting Room

Published: December 08, 2025 • Categories: Partnering, Business Development, Global Biopharma

As the year draws to a close, for many in the life sciences sector, this period isn’t merely about holiday preparations; it signals the imminent start of the annual pilgrimage to the J.P. Morgan Healthcare Conference (JPMHC). For emerging companies, particularly those focused on showcasing proprietary assets, securing critical investment,...

Choose Your Battlefield: Why the EU Might Outpace the US in the Digital Health Revolution

Published: December 01, 2025 • Categories: Digital Health, Global Policy, Investment, Technology

The digital health industry is experiencing a global boom, but the paths to success diverge significantly across the Atlantic. While both the European Union and the United States are seeing rapid growth in telehealth, AI, and chronic disease management, the underlying market dynamics, regulatory environments, and investment climates paint a...

MiRNA: Nobel Glory, Clinical Failure—Unpacking the Crisis of the 'Next Generation' RNA Drug

Published: November 17, 2025 • Categories: RNA, R&D, Technology

The Genesis of Breakthroughs: Abu Dhabi as the Middle East's Premier R&D and Precision Medicine Hub

Published: November 10, 2025 • Categories: R&D, Global Biopharma, Global Policy

A Tale of of RNA Manufacturing

Published: November 03, 2025 • Categories: Manufacturing, RNA, Technology

The Rebound of Healthcare IPOs in APAC in the First Half of 2025

Published: October 27, 2025 • Categories: IPO, Investment, Startup, Global Biopharma

Dubai: The Ascendant Hub for Biotech Manufacturing, Distribution, and Commercialization in the Middle East

Published: October 20, 2025 • Categories: Manufacturing, Supply Chain, Global Biopharma, Global Policy

A brief Introduction of Antibody-Bottlebrush Prodrug Conjugates (ABCs)

Published: October 13, 2025 • Categories: ADC, Biologics, Technology, R&D

A recent publication by a group of talented chemists at MIT unveils a next-generation platform called Antibody-Bottlebrush prodrug Conjugates (ABCs) for targeted cancer therapy, designed to overcome limitations of traditional Antibody-Drug Conjugates (ADCs).

A Baroque Crescendo in European Biotech Funding in 2025

Published: October 06, 2025

Navigating the Regulatory Maze in the Gulf Cooperation Council countries

Published: September 29, 2025

Beyond the Lab: Singapore's Rise as a Global Biopharma CDMO Powerhouse

Published: September 22, 2025

A New Era of AI investment in Biopharma

Published: September 16, 2025 • Categories: Strategy, Industry Trends